Dentsply Sirona: Was Your “Affordable” Smile Worth the Risk of Permanent Tooth Damage?

The Billion-Dollar Smile That Cost People Their Teeth

Dentsply Sirona, a global dental equipment juggernaut, paid $1.04 billion in cash for a company called Byte. Byte’s business model was simple: sell the promise of a perfect smile directly to people at home, cutting out the costly and time-consuming visits to an orthodontist. They targeted people who felt priced out of the market, using slick marketing about “making the inaccessible, accessible.” A class-action lawsuit filed in the Southern District of Florida alleges this billion-dollar bet was built on a foundation of deception that left a trail of physical pain, financial ruin, and shattered trust for countless customers.

The company sold its “Byte Aligner Systems” with the assurance of professional oversight, claiming treatment plans were “Doctor directed” by a “nationwide network of licensed dentists and orthodontists.” Customers, believing they were receiving safe and remote medical care, made molds of their own teeth and received plastic aligners in the mail. But the legal complaint details a horrifying reality. Instead of confidence, many customers allegedly received misaligned bites, gum recession, fractured teeth, and even dead teeth. The lawsuit accuses Byte and Dentsply Sirona of selling a dangerous and defective product, fully aware of the harm it was causing, while systematically failing to report these “adverse events” to regulators or the public.

The Non-Financial Ledger

The price tag on a Byte Aligner System was $3,338.02, paid in installments by people who, in the company’s own words, belonged to “disadvantaged socio-economic groups.” But the true cost isn’t measured in dollars. It’s measured in the currency of human dignity and physical well-being. The company’s marketing was a masterclass in emotional manipulation, promising to help people “own their smiles, proudly and confidently.” It was a direct appeal to a deep-seated insecurity, packaged as empowerment for those who had been told that a straight smile was a luxury they couldn’t afford.

The betrayal cuts deep. Imagine saving up, signing a payment contract, and eagerly awaiting the kit that promises to change your life, only for it to bring agonizing pain. The plaintiff, Paula J. Phillips, experienced pain and bleeding in her mouth within a month of using the product. The aligners, meant to gently shift teeth, allegedly cut gums, caused jaw clicking, and in hundreds of other reported cases, led to irreversible damage like bone loss and periodontal disease. The promise of confidence became a new source of shame and fear. The dream of a better smile twisted into a nightmare of emergency dental appointments and the terrifying possibility of losing your teeth entirely.

This is the cold calculus of the direct-to-consumer medical industry when it goes unchecked. The “team of real humans who care deeply about you,” as Byte’s website claimed, allegedly vanished when customers like Ms. Phillips needed help. When she inquired about a refund for the product that was hurting her, the website stated that no refunds were available. You are left alone, in pain, with a defective medical device, still making payments to the very corporation that harmed you. The business model removes the human safety net of a real doctor’s office and replaces it with a customer service firewall designed to protect profits, not patients.

“They openly admit to targeting disadvantaged socio-economic groups on their website by claiming that ‘A straighter smile was once only reserved for certain groups of people. We set out to change that…'”

The ledger records more than just physical injuries. It records the theft of hope. Byte didn’t just sell plastic trays; it sold access to a social status, a key to confidence that many people felt was locked away from them. To have that hope turn into a source of physical and financial trauma is a profound violation. It reinforces the cruelest messages of a stratified society: that affordable options are traps, that you get what you pay for, and that if you can’t afford the premium version, you deserve the pain that comes with the alternative. This is the unquantifiable damage left behind when a corporation sees people’s deepest insecurities as a market to be exploited.

Legal Receipts

The evidence against Byte and Dentsply Sirona is laid out in their own words, sourced directly from their marketing materials, SEC filings, and the class-action complaint. These are not interpretations; they are the documented statements at the heart of the case.

Marketing Promise: “At Byte, we believe in making the inaccessible, accessible. Our oral care platform makes it easier and more affordable for many people to get the smile and confidence they’ve been dreaming about.”
The “Doctor Directed” Claim: “Your treatment plan is reviewed and prescribed by a dentist. Your clinical team is available to help monitor your progress.”
Parent Company’s SEC Filing (March 1, 2022): Defendant Dentsply explained that it “contracts with an expansive nationwide network of independent licensed dentists and orthodontists for the provision of clinical services, including the oversight and control of each customer’s clinical treatment in order to comply with these regulations…”
The Sudden Halt (October 24, 2024): Defendants announced they were indefinitely suspending sales and marketing of the Byte Aligner Systems and Impression Kits “while the Company conducts a review of certain regulatory requirements related to these products.”
The Company’s Admission (October 25, 2024): “…we have determined that our patient onboarding workflow may not provide adequate assurance that certain contraindicated patients do not enter treatment with Byte Aligners…we made the decision to voluntarily pause shipment and processing of new and recently placed orders…”
The Damage Report: “From October 2020 to October 2024, there were hundreds of incidents involving adverse events associated with the Byte Aligner Product. These incidents involved a broad range of complications suffered by customers…” The complaint goes on to list 18 specific, severe conditions.
Regulatory Failure: “And Defendants lacked essential feedback loops to timely advise regulators and, by extension the public, of adverse incidents involving their products.”

Societal Impact Mapping

A corporation’s actions ripple outwards, affecting more than just their immediate customers. The business model pioneered by Byte and acquired by Dentsply Sirona has specific, measurable impacts on our collective health and economic stability.

Environmental Degradation

The court filing focuses entirely on the human and financial costs of the Byte Aligner system. It provides no data or testimony regarding the environmental impact of the product. The business model relies on mailing single-use plastic impression kits to consumers, who then mail them back. Subsequently, multiple sets of custom plastic aligners, each worn for a short period, are manufactured and shipped. The full lifecycle impact of this plastic-intensive, shipping-heavy model, from production to disposal, is not addressed in the provided source material.

Public Health

The public health implications are catastrophic. By sidestepping mandatory, in-person consultations with a qualified orthodontist, the direct-to-consumer model eliminates critical diagnostic safeguards. A real orthodontist performs a comprehensive exam, including X-rays, to assess jaw structure, bone density, and gum health before ever prescribing treatment. Moving teeth is a complex medical procedure, and doing so without this data is reckless.

The lawsuit alleges the consequences of this negligence are severe and widespread. The legal complaint lists at least 500 reported adverse events and provides a chilling catalog of medical injuries linked to the product, including: Bite misalignment, Bone loss, Breaking and chipping of teeth, Choking on aligners due to poor fit, Cutting of gums, Facial swelling and abscess, Gum recession, Jaw clicking, Locked jaw, Loosening of teeth, Periodontal disease, Pulp necrosis resulting in a dead tooth, Severe open bite, and Worsening of patient bite. This isn’t a simple case of a product not working. This is a public health crisis masquerading as a beauty product, where a company’s pursuit of market share allegedly created a new wave of patients with complex, painful, and expensive medical problems.

Economic Inequality

Byte’s business strategy was a textbook example of predatory inclusion. The company explicitly targeted financially vulnerable people, acknowledging on its website that “A straighter smile was once only reserved for certain groups of people.” They sold a solution, but the lawsuit argues it was a trap. By offering a seemingly cheaper alternative to a service often not covered by insurance, they lured in customers who could least afford a negative outcome.

The result is a vicious cycle of debt and damage. A customer signs an installment contract for over $3,300. The product then causes physical harm that requires expensive corrective treatment from the very professionals it claimed to replace. The victim is now saddled with the original debt to Byte, plus new, unexpected medical bills for fixing the damage. The company gets its money, while the customer is left financially worse off and in physical pain. This model does not “democratize” healthcare; it monetizes desperation and deepens the economic divide by extracting wealth from lower-income communities and leaving them with compounding health problems.

$1.04 Billion

All-cash price Dentsply Sirona paid for a business model that generated at least 500 documented medical injury reports, including bone loss, dead teeth, and locked jaws.

What Now?

Accountability does not end with a lawsuit. The corporate structure is designed to shield decision-makers from the consequences of their actions. While this case proceeds, it is critical to keep the pressure on the individuals and regulators who hold the power.

Corporate Roles on Watch

  • Board of Directors, Dentsply Sirona Inc.
  • Chief Executive Officer, Dentsply Sirona Inc.
  • Leadership Team, Straight Smile LLC (d/b/a Byte)

Regulatory Watchlist

  • Food and Drug Administration (FDA): For its oversight of direct-to-consumer medical devices and review of the 500+ adverse event reports.
  • Federal Trade Commission (FTC): For investigating the company’s allegedly false and deceptive advertising practices.
  • Securities and Exchange Commission (SEC): For reviewing Dentsply’s public statements to investors regarding the safety and oversight of its billion-dollar acquisition.
  • State Attorneys General: To enforce state-level consumer protection laws like the Florida Deceptive and Unfair Trade Practices Act.

This is not a spectator sport. Support class-action lawsuits that give individuals a fighting chance against corporate giants. Demand that your state’s Attorney General investigate direct-to-consumer medical companies. Organize mutual aid networks to help victims of corporate negligence pay for the corrective care they now desperately need. The system is designed to wear you down; our collective power is the only thing that can wear it out.

The source document for this investigation is attached below.

💡 Explore Corporate Misconduct by Category

Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.

Aleeia
Aleeia

I'm Aleeia, the creator of this website.

I have 6+ years of experience as an independent researcher covering corporate misconduct, sourced from legal documents, regulatory filings, and professional legal databases.

My background includes a Supply Chain Management degree from Michigan State University's Eli Broad College of Business, and years working inside the industries I now cover.

Every post on this site was either written or personally reviewed and edited by me before publication.

Learn more about my research standards and editorial process by visiting my About page

Articles: 1742
🏳️‍⚧️ trans rights are human rights 🏳️‍⚧️
Theme